News
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A ...
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the ...
US order books at Smurfit Westrock are steadying after "a lot of weakness" in March and early April amid falling consumer ...
An effort to allow Boulder voters to decide on closing a western portion of Pearl Street to cars came to an abrupt end ...
The stock's fall snapped a two-day winning streak.
8d
Zacks Investment Research on MSNWest Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat EstimatesWest Pharmaceutical Services (WST) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $1.56 per share a year ago ...
Bernard Birkett, senior VP, CFO, informed West of his intention to step down from his current position this year. West has commenced a search ...
GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States ...
Stephens resumed coverage of West Pharmaceutical (WST) with an Overweight rating and $250 price target The firm calls West “a high-quality, ...
In this article, we are going to take a look at where West Pharmaceutical Services, Inc. (NYSE:WST) stands against other low profile dividend champions. Companies known as Dividend Aristocrats ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results